Total Payments
$441,754
2024 Payments
$23,051
Companies
38
Transactions
785
Medicare Patients
249
Medicare Billing
$33,152
Payment Breakdown by Category
Other$363,214 (82.2%)
Travel$42,883 (9.7%)
Consulting$21,000 (4.8%)
Food & Beverage$14,443 (3.3%)
Education$214.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250,452 | 138 | 56.7% |
| Honoraria | $112,763 | 42 | 25.5% |
| Travel and Lodging | $42,883 | 167 | 9.7% |
| Consulting Fee | $21,000 | 9 | 4.8% |
| Food and Beverage | $14,443 | 421 | 3.3% |
| Education | $214.40 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $118,625 | 130 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $115,468 | 227 | $0 (2020) |
| UCB, Inc. | $105,865 | 198 | $0 (2024) |
| Eisai Inc. | $43,362 | 77 | $0 (2021) |
| Neurelis, Inc. | $42,040 | 47 | $0 (2024) |
| Lundbeck LLC | $10,515 | 33 | $0 (2022) |
| West Therapeutics Development, LLC | $2,800 | 3 | $0 (2019) |
| Aprecia Pharmaceuticals, LLC | $1,160 | 1 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $364.88 | 6 | $0 (2024) |
| Greenwich Biosciences, Inc. | $142.58 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,051 | 62 | UCB, Inc. ($10,903) |
| 2023 | $32,004 | 40 | SK Life Science, Inc. ($22,986) |
| 2022 | $66,068 | 91 | SK Life Science, Inc. ($48,550) |
| 2021 | $26,201 | 29 | SK Life Science, Inc. ($11,407) |
| 2020 | $37,957 | 58 | SK Life Science, Inc. ($27,509) |
| 2019 | $43,774 | 126 | EISAI INC. ($24,065) |
| 2018 | $107,069 | 190 | Sunovion Pharmaceuticals Inc. ($61,135) |
| 2017 | $105,631 | 189 | Sunovion Pharmaceuticals Inc. ($53,883) |
All Payment Transactions
785 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Neurology | ||||||
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Neurology | ||||||
| 12/12/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $135.36 | General |
| Category: Neurology | ||||||
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.10 | General |
| 12/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $107.75 | General |
| Category: EPILEPSY | ||||||
| 12/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.59 | General |
| 12/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $30.62 | General |
| 12/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.92 | General |
| 12/02/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Neurology | ||||||
| 11/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.00 | General |
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,036.00 | General |
| Category: EPILEPSY | ||||||
| 11/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Nayzilam (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | Cash or cash equivalent | $328.30 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $78.00 | General |
| Category: EPILEPSY | ||||||
| 10/30/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Immunology and Neurology | ||||||
| 10/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.77 | General |
| 10/16/2024 | UCB, Inc. | Nayzilam (Drug) | Travel and Lodging | In-kind items and services | $265.50 | General |
| Category: Neurology | ||||||
| 10/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $104.62 | General |
| Category: Neurology | ||||||
| 10/15/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 6 | 249 | 345 | $112,850 | $33,152 |
Total Patients
249
Total Services
345
Medicare Billing
$33,152
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 69 | 149 | $36,356 | $21,216 | 58.4% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 46 | 52 | $8,216 | $5,447 | 66.3% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 85 | 92 | $49,036 | $4,118 | 8.4% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 19 | 19 | $11,571 | $893.20 | 7.7% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Facility | 2020 | 12 | 12 | $2,736 | $850.01 | 31.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 18 | 21 | $4,935 | $627.15 | 12.7% |
About Dr. Richard Ramsay, MD
Dr. Richard Ramsay, MD is a Epilepsy healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790740694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Ramsay, MD has received a total of $441,754 in payments from pharmaceutical and medical device companies, with $23,051 received in 2024. These payments were reported across 785 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($250,452).
As a Medicare-enrolled provider, Ramsay has provided services to 249 Medicare beneficiaries, totaling 345 services with total Medicare billing of $33,152. Data is available for 1 year (2020–2020), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Epilepsy, Epilepsy
- Location Mobile, AL
- Active Since 04/20/2006
- Last Updated 04/25/2024
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1790740694
Products in Payments
- APTIOM (Drug) $115,413
- XCOPRI (Drug) $96,077
- Briviact (Drug) $71,758
- Fycompa (Drug) $43,362
- VALTOCO (Drug) $42,040
- Vimpat (Drug) $22,908
- Cenobamate (Drug) $21,580
- Nayzilam (Drug) $10,688
- ONFI (Drug) $10,389
- Spritam (Drug) $1,160
- Cosyntropin (Drug) $1,050
- EPIDIOLEX (Drug) $364.88
- Fintepla (Drug) $287.52
- Epidiolex (Drug) $142.58
- QUVIVIQ (Drug) $125.00
- VYVGART HYTRULO (Drug) $111.81
- VNS Therapy (Device) $102.61
- Aimovig (Biological) $94.81
- NORTHERA (Drug) $79.66
- NUPLAZID (Drug) $70.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.